| MTX110 Development for the Treatment of Glioma | RNS | 21.06.22 | 07:00:03 |
| Directorate Change | RNS | 20.06.22 | 17:58:00 |
| Result of 2022 Annual General Meeting | RNS | 20.06.22 | 14:33:25 |
| MTX110 Study to be Presented at ISPNO 2022 | Reach | 10.06.22 | 07:00:08 |
| Retirement of Chairman and Proposed New Chairman | RNS | 10.06.22 | 07:00:08 |
| Fast Track Designation for MTX110 Development | RNS | 01.06.22 | 12:23:46 |
| Posting of Annual Report & Notice of AGM | RNS | 24.05.22 | 11:09:44 |
| Issue of Equity for Employee Share Incentive Plan | RNS | 27.04.22 | 13:00:15 |
| Results for the Year Ended 31 December 2021 | RNS | 26.04.22 | 07:00:14 |
| Receipt of NASDAQ Notice | RNS | 14.04.22 | 12:37:51 |
| Exercise of Warrants and Issue of Equity | RNS | 17.03.22 | 07:00:04 |
| R&D collaboration with Janssen on second molecule | RNS | 09.03.22 | 07:00:08 |
| Appointment of Nominated and Financial Adviser | RNS | 08.03.22 | 09:30:07 |
Holding(s) in Company 09 February 2022 13:53:23 | RNS | 09.02.22 | 13:53:23 |
| Holding(s) in Company | RNS | 18.01.22 | 16:18:56 |
| Extension of Janssen collaboration re Q-Sphera | RNS | 17.01.22 | 07:00:06 |
| Holding(s) in Company | RNS | 07.01.22 | 17:37:38 |
IND Application for MTX110 Study in GBM Effective 13 December 2021 09:43:06 | RNS | 13.12.21 | 09:43:06 |
Midatech presenting at MelloMonday 03 December 2021 07:00:05 | Reach | 03.12.21 | 07:00:05 |
Midatech presenting at the Shares/AJ Bell Webinar 24 November 2021 07:00:04 | Reach | 24.11.21 | 07:00:04 |
